Canada Markets closed

PolarityTE, Inc. (PTE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5200+0.0700 (+4.83%)
At close: 04:00PM EDT
1.5300 +0.01 (+0.66%)
After hours: 07:45PM EDT

PolarityTE, Inc.

1960 South 4250 West
Salt Lake City, UT 84104
United States
800 560 3983

Full Time Employees59

Key Executives

NameTitlePayExercisedYear Born
Mr. Richard HaguePres & CEO649.26kN/A1960
Mr. Cameron J. Hoyler J.D.Gen. Counsel, Sec., EVP of Corp. Devel. & Strategy and Chief Compliance Officer623.19kN/A1984
Mr. Jacob Alexander PattersonChief Financial OfficerN/AN/A1979
Mr. Nikolai SopkoChief Scientific Officer and VP of R&DN/AN/AN/A
Mr. Rich HaerleVP of Investor Relations & StrategyN/AN/AN/A
Angela ZieglerVP of Marketing & PRN/AN/AN/A
Mr. Alain AdamVP of SalesN/AN/AN/A
Dr. Stephen Milner M.D., DDS, DSc, FRCSE, FACSChief Clinical Officer & Member of Clinical Advisory BoardN/AN/A1949
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D.Sr. VP of Corp. Devel. & Pres of Contract ServicesN/AN/A1963
Mr. Ryan Mathis M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.

Corporate Governance

PolarityTE, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.